Rigel Pharmaceuticals
RIGL
#6160
Rank
HK$6.90 B
Marketcap
HK$380.61
Share price
3.25%
Change (1 day)
111.24%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2025 (TTM): HK$0.95 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are HK$0.28 Billion. In 2024 the company made an earning of HK$0.20 Billion, an increase over its 2023 earnings that were of -HK$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$0.95 B365.8%
2024 HK$0.20 B-244.27%
2023 -HK$0.15 Billion-66.79%
2022 -HK$0.43 Billion340.73%
2021 -HK$96.86 Million-56.15%
2020 -HK$0.23 Billion-57.34%
2019 -HK$0.52 Billion-7.66%
2018 -HK$0.57 Billion-9.47%
2017 -HK$0.62 Billion24.46%
2016 -HK$0.5 Billion23.63%
2015 -HK$0.41 Billion-43.29%
2014 -HK$0.71 Billion2.5%
2013 -HK$0.7 Billion
2010 HK$0.29 B-133.97%
2009 -HK$0.87 Billion-18.49%
2008 -HK$1.07 Billion71.91%
2007 -HK$0.62 Billion84.74%
2006 -HK$0.34 Billion-10.17%
2005 -HK$0.38 Billion-15.73%
2004 -HK$0.45 Billion39.29%
2003 -HK$0.32 Billion10.3%
2002 -HK$0.29 Billion48.3%
2001 -HK$0.2 Billion-2.13%
2000 -HK$0.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ChemoCentryx
CCXI
-HK$1.02 Billion-207.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-HK$0.85 Billion-189.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$101.84 B 10,637.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Amgen
AMGN
HK$64.14 B 6,662.31%๐Ÿ‡บ๐Ÿ‡ธ USA